Trials / Recruiting
RecruitingNCT07351253
Erector Spinae Plane Block Versus Lateral Transversus Abdominis Plane Block for Open Abendectomy Surgery
Analgeisc Effect of Erector Spinae Plane Block Versus Lateral Transversus Abdominis Plane Block in Patients Undergoing Open Abendectomy Surgery: a Randomized Controlled Trial
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 68 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
this aim of this study is to compare the analgesic effect of Erector spinae plane (ESP) block and lateral transversus abdominis plan (TAP) block in patients undergoing open appendectomy.
Detailed description
regional technique according to randomization will be given after induction of general anesthesia Fentanyl boluses of 1 mcg/kg will be given in case of inadequate analgesia. Inadequate analgesia identified by 20% increase in the heart rate and/or systolic blood pressure from baseline measurement. postoperative analgesia: regular paracetamol 1 g/6 hours (intravenously at first then orally once the oral feeding is resumed) and 75 mg diclofenac (intramuscularly at first then orally once the oral feeding is resumed). If Numeric rating scale (NRS) is \> 3 intravenous titration of 2 mg morphine is given slowly to be repeated after 30 minutes if pain persisted
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Erector Spinae Plane Block | Patients will receive the ESP block at the level of the 10th thoracic (T10) transverse process using a linear 6-13 MHz ultrasound transducer. A 20 mL of 0.25% bupivacaine will be injected below the muscle |
| OTHER | Transversus abdominis plane (TAP) block | Patient will received TAP block using the lateral approach while in supine position. A 20 mL of 0.25% bupivacaine will be injected after negative aspiration. |
Timeline
- Start date
- 2026-01-25
- Primary completion
- 2026-05-01
- Completion
- 2026-05-01
- First posted
- 2026-01-20
- Last updated
- 2026-03-17
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT07351253. Inclusion in this directory is not an endorsement.